Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring

WorldPing

The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

Related news

CNBC World•

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 150%

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Brief by WorldPing · Original reporting by CNBC World

WorldPing

Ars Technica•

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer's return and spread.

Brief by WorldPing · Original reporting by Ars Technica

WorldPing

BBC Health•

Vaccine breakthrough stops cancer returning in trial

A new jab extended the length of time patients were cancer free, but it is unclear for how long.

Brief by WorldPing · Original reporting by BBC Health

WorldPing

NPR Top•

A real-world study of Oregon's nonmedical psilocybin program shows promise

Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the latest data from the state's real-life experiment.

Brief by WorldPing · Original reporting by NPR Top

WorldPing

The Guardian•

What has Burnham promised since he became PM, and when will it happen?

From cutting household bills to moving power out of Westminster, how will the measures announced unfold?

Brief by WorldPing · Original reporting by The Guardian

WorldPing

Fortune•

A Democratic Socialist just defeated a central figure in Trump’s first impeachment trial in a Florida primary

Alexander Vindman congratulated Angie Nixon for running a strong campaign: "I will be standing by her side in the fight against Ashley Moody."…

Brief by WorldPing · Original reporting by Fortune